News

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and nutrition.
Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...